Commonwealth Cancer Consortium Inc
501C3 Nonprofit Organization Information
Commonwealth Cancer Consortium Inc is a 501(c)(3) charitable nonprofit in Cambridge, Massachusetts (EIN 85-1681659). It has been tax-exempt since May 2021, and contributions to it are tax-deductible. Its Form 990 for tax year 2024 reports total revenue of $13,409,685 and net assets of $55,946,368. TaxExemptWorld has Form 990s on file for 3 tax years (2022–2024). It is one of 2,605 nonprofits in Cambridge, MA.
Form 990 · Tax period ending Dec 2024 · Filed Oct 14, 2025 · From the IRS e-file data
Dollar amounts for every revenue and expense line are in the full 990 report.
Mission (as filed): BREAK THROUGH CANCER IS A FOUNDATION DEDICATED TO SUPPORTING TRANSLATIONAL RESEARCH IN THE MOST DIFFICULT TO TREAT CANCERS. OUR PARTNER ORGANIZATIONS ARE AMONG THE TOP CANCER RESEARCH CENTERS AND TOGETHER, REPRESENT SOME OF THE MOST BRILLIANT, CREATIVE MINDS IN THE COUNTRY. WE BELIEVE BREAK THROUGH CANCER IS THE BEGINNING OF A SCIENTIFIC MOVEMENT THAT ACCEPTS NOTHING LESS THAN MULTI-INSTITUTIONAL COLLABORATION IN PATIENT CENTRIC CANCER RESEARCH. THE FOUNDATION WILL WORK CLOSELY WITH TEAMS OF SCIENTISTS, ENGINEERS, AND CLINICAL RESEARCHERS TO FOCUS ON DIAGNOSING, TREATING, AND IDEALLY CURING SOME OF THE MOST INTRACTABLE FORMS OF CANCER. WHILE MANY PATIENTS HAVE BENEFITED FROM ADVANCES IN RESEARCH AND TECHNOLOGY, THERE ARE FAR TOO MANY WHO HAVE BEEN LEFT BEHIND. THERE ARE TOO MANY CANCERS WHERE THE NEEDLE REMAINS UNMOVED. BREAK THROUGH CANCER IS COMMITTED TO MAKING HEADWAY IN THESE EXTREMELY COMPLEX, CHALLENGING DISEASES, AND COMMITTED TO FINDING HOPE FOR PATIENTS AND THEIR FAMILIES.
PROVIDES FUNDING TO TEAMS OF RESEARCHERS FROM THE FIVE TOP CANCER RESEARCH CENTERS: DANA-FARBER CANCER INSTITUTE, THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHN HOPKINS, MASSACHUSETTS INSTITUTE OF TECHNOLOGY'S KOCH INSTITUTE FOR INTEGRATIVE CANCER RESEARCH, THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER, AND MEMORIAL SLOAN KETTERING CANCER CENTER IN ORDER TO HELP INTERCEPT CANCER EARLY, DEVELOP MORE EFFECTIVE TREATMENTS, AND ACCELERATE CURES FOR SOME OF THE DEADLIEST CANCERS.
Public charity (509(a)(1), 170(b)(1)(A)(vi))
Prepared by TaxExemptWorld from IRS Form 990 e-file data (object ID 202502879349301140). Not an official IRS form.